Generic drugs
When patents expire on brand-name drugs and generic formulations become available, patients and managed care organizations may express a preference for the lower-cost generics. Are they equivalent to the brand-name product?...
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Generic drugs
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1141
Article Code: 1141c
Date: October 14, 2002
Volume: 44
Pages: 89-90
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1141
Article Code: 1141c
Date: October 14, 2002
Volume: 44
Pages: 89-90
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)